US FDA stops notarizing device export certificates, but enhances online application tool
This article was originally published in SRA
The US Food and Drug Administration has discontinued its practice of notarizing medical device export certificates1 and manufacturers will now have to apply to another government department for the authentication. At the same time, the agency is enhancing its voluntary online system for allowing manufacturers to request export documents more efficiently than by submitting their applications on paper2.
You may also be interested in...
New medicines under evaluation at the European Medicines Agency.
Pfizer’s abrocitinib and Biogen/Eisai’s aducanumab are among a host of new investigational products that are under review by the European Medicines Agency.
GenSight Biologics believes Lumevoq could become the first curative treatment for Leber hereditary optic neuropathy.